Skip to main content
Top

Supportive Care in Cancer

Issue 3/2009

Content (13 Articles)

Letter to the Editor

Seizure associated with palonosetron

Alberto Zambelli, Paola Sagrada, Lorenzo Pavesi

Original Article

Life goals and purpose in life in cancer patients

Martin Pinquart, Rainer K. Silbereisen, Cornelia Fröhlich

Original Article

Descriptive analysis of clinical factors affecting terminally ill cancer patients

A. M. Jiménez-Gordo, J. Feliu, B. Martínez, J. de-Castro, N. Rodríguez-Salas, N. Sastre, Y. Vilches, E. Espinosa, J. R. Rodríguez-Aizcorbe, M. González-Barón

Original Article

Age-specific correlates of quality of life in Chinese women with cervical cancer

Beatrice P. Y. Lai, Catherine So-kum Tang, Tony K. H. Chung

Original Article

The benefits of prayer on mood and well-being of breast cancer survivors

Ellen G. Levine, Caryn Aviv, Grace Yoo, Cheryl Ewing, Alfred Au

Original Article

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

Richard J. Gralla, Martin J. Edelman, Frank C. Detterbeck, Thierry M. Jahan, David M. Loesch, Steven A. Limentani, Ramaswamy Govindan, Guangbin Peng, Matthew J. Monberg, Coleman K. Obasaju, Mark A. Socinski

Original Article

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

Tsutomu Yoshida, Toshiyuki Sawa, Takashi Ishiguro, Akane Horiba, Shinya Minatoguchi, Hisayoshi Fujiwara

Short Communication

Clostridium difficile-associated disease in children with solid tumors

Elio Castagnola, Teresa Battaglia, Roberto Bandettini, Ilaria Caviglia, Ivana Baldelli, Marilina Nantron, Cristina Moroni, Alberto Garaventa

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine